Cargando…

Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment

SIMPLE SUMMARY: Microtubule-interfering drugs have been used alone or in combination in the treatment of epithelial ovarian cancer. Over the years and with increasing chemoresistance to taxanes, epothilones (i.e., ixabepilone) have become of interest as alternatives to taxanes. In this review, we di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tymon-Rosario, Joan, Adjei, Naomi N., Roque, Dana M., Santin, Alessandro D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699494/ https://www.ncbi.nlm.nih.gov/pubmed/34944858 http://dx.doi.org/10.3390/cancers13246239

Ejemplares similares

Sacituzumab govitecan: a promising antibody-drug conjugate for the treatment of poorly differentiated endometrial cancer
por: Webster, Emily M., et al.
Publicado: (2020)

Opsoclonus-ataxia syndrome and mature ovarian teratoma in an adolescent
por: Webster, Emily M., et al.
Publicado: (2020)

The role of microtubules in the regulation of epithelial junctions
por: Vasileva, Ekaterina, et al.
Publicado: (2018)

Association between diabetes mellitus and progression free survival in women with ovarian granulosa cell tumors
por: Tymon-Rosario, Joan R., et al.
Publicado: (2018)

Bortezomib antagonizes microtubule-interfering drug-induced apoptosis by inhibiting G2/M transition and MCL-1 degradation
por: Rapino, F, et al.
Publicado: (2013)

Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer
por: Roque, Dana M., et al.
Publicado: (2022)

Response to microtubule-interacting agents in primary epithelial ovarian cancer cells
por: Pellicciotta, Ilenia, et al.
Publicado: (2013)

The novel microtubule-interfering agent TZT-1027 enhances the anticancer effect of radiation in vitro and in vivo
por: Akashi, Y, et al.
Publicado: (2007)

Sequential events of apoptosis involving docetaxel, a microtubule-interfering agent: A cytometric study
por: Fabbri, Francesco, et al.
Publicado: (2006)

Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction
por: Chiang, Ying-Cheng, et al.
Publicado: (2021)

Selective Reduction of a Heterotopic Cesarean Scar Pregnancy Complicated by Septic Abortion
por: Tymon-Rosario, Joan, et al.
Publicado: (2018)

Multidrug-Resistant Escherichia coli Resulting in Postpartum Necrotizing Endomyometritis
por: Tymon-Rosario, Joan, et al.
Publicado: (2019)

Interfering with mineralocorticoid receptor activation: the past, present, and future
por: Dorrance, Anne M.
Publicado: (2014)

Downregulation of matrix metalloproteinase 9 by small interfering RNA inhibits the tumor growth of ovarian epithelial carcinoma in vitro and in vivo
por: Guo, Fengjun, et al.
Publicado: (2021)

Role of the microtubule-targeting drug vinflunine on cell-cell adhesions in bladder epithelial tumour cells
por: Aparicio, Luis A, et al.
Publicado: (2014)

Current Status and Evolution of Preclinical Drug Development Models of Epithelial Ovarian Cancer
por: Konstantinopoulos, Panagiotis A., et al.
Publicado: (2013)

Targeting the Epidermal Growth Factor Receptor in Epithelial Ovarian Cancer: Current Knowledge and Future Challenges
por: Siwak, Doris R., et al.
Publicado: (2010)

Maintenance therapy for recurrent epithelial ovarian cancer: current therapies and future perspectives – a review
por: Gupta, Sudeep, et al.
Publicado: (2019)

Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38), in Ovarian Cancer
por: Perrone, Emanuele, et al.
Publicado: (2020)

Male hormone-interfering drugs and meningioma development
por: Giraldi, Laura, et al.
Publicado: (2019)

Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
por: Ho, Gwo Yaw, et al.
Publicado: (2022)

Blockade of GRP78 sensitizes breast cancer cells to microtubules-interfering agents that induce the unfolded protein response
por: Wang, Jiao, et al.
Publicado: (2009)

Panobinostat Synergistically Enhances the Cytotoxicity of Microtubule Destabilizing Drugs in Ovarian Cancer Cells
por: Ovejero-Sánchez, María, et al.
Publicado: (2022)

Sonoelastography in the musculoskeletal system: Current role and future directions
por: Winn, Naomi, et al.
Publicado: (2016)

Introducing variability in targeting the microtubules: Review of current mechanisms and future directions in colchicine therapy
por: Forkosh, Esther, et al.
Publicado: (2020)

Inhibition of Growth and Metastasis of Ovarian Carcinoma by Administering a Drug Capable of Interfering with Vascular Endothelial Growth Factor Activity
por: Mu, Jie, et al.
Publicado: (1996)

Current and future immunotherapy approaches in ovarian cancer
por: Demircan, Nazım Can, et al.
Publicado: (2020)

Liquid Biopsy in the Clinical Management of High-Grade Serous Epithelial Ovarian Cancer—Current Use and Future Opportunities
por: Paracchini, Lara, et al.
Publicado: (2021)

Preclinical activity of sacituzumab govitecan (IMMU-132) in uterine and ovarian carcinosarcomas
por: Lopez, Salvatore, et al.
Publicado: (2020)

Pegylated liposomal doxorubicin: appraisal of its current role in the management of epithelial ovarian cancer
por: Markman, Maurie
Publicado: (2011)

Interfering with transmission
por: Wack, Andreas
Publicado: (2018)

Interfering with Colds
Publicado: (2013)

Delivery of therapeutic small interfering RNA: The current patent-based landscape
por: Chen, Yu, et al.
Publicado: (2022)

Right ventricular failure: Current strategies and future development
por: Monteagudo-Vela, María, et al.
Publicado: (2023)

Robotic radical trachelectomy with an abdominally placed vaginal cerclage for containment of early stage cervical cancer()
por: Tymon-Rosario, Joan, et al.
Publicado: (2020)

Robotic interval debulking with radical hysterectomy and partial urinary bladder resection for locally advanced carcinosarcoma of the uterus
por: Harold, Justin, et al.
Publicado: (2022)

Drugs Interfering with Muscarinic Acetylcholine Receptors and Their Effects on Place Navigation
por: Svoboda, Jan, et al.
Publicado: (2017)

Lumiflavin increases the sensitivity of ovarian cancer stem‐like cells to cisplatin by interfering with riboflavin
por: Yang, Ruhui, et al.
Publicado: (2019)

Microtubules regulate disassembly of epithelial apical junctions
por: Ivanov, Andrei I, et al.
Publicado: (2006)

Microtubules are stabilized in confluent epithelial cells but not in fibroblasts
Publicado: (1990)

Cannot write session to /tmp/vufind_sessions/sess_c9pso3mbr86ugcj53e7ljfjp5b